PEN Q3 2021 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$190M+25.8% YoY

Gross Profit

$120M63.1% margin

Operating Income

$9M4.6% margin

Net Income

$9M4.7% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$973M

Total Liabilities

$289M

Stockholders' Equity

$691M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$190M	$151M	+25.8%
Gross Profit	$120M	$91M	+31.9%
Operating Income	$9M	-$20M	+143.6%
Net Income	$9M	-$9M	+200.4%

Revenue Segments

Peripheral Vascular

$105M55%

Neuro

$85M45%

Geographic Segments

UNITED STATES

$135M71%

Other Non-US

$55M29%